Page 438 - Problem-Based Feline Medicine
P. 438

430   PART 7   SICK CAT WITH SPECIFIC SIGNS


          ● Administer ursodeoxycholic acid for choleresis and
                                                        FELINE INFECTIOUS PERITONITIS (FIP)*
            modulation of “noxious” bile acids.
          ● Long-term immunosuppressive therapy (steroids
            +/− metronidazole) is often required in cats with  Classical signs
            persistent clinical signs or abnormal laboratory
                                                         ● 50% of cats are < 2 years of age.
            values. Some cats that fail to respond to pred-
                                                         ● Weight loss, anorexia, vomiting and
            nisone may respond to chlorambucil (0.2 mg/kg
                                                           lethargy.
            PO q 48 h).
                                                         ● Jaundice +/- cyclical fever.
          Supportive care as dictated by the animal’s needs.  ● Protein-rich ascites in “effusive” form.
          ● Vitamin K for coagulopathy (3–5 mg per cat PO q
                    1
            24 hours as needed).                        See main reference, page 372 (The Pyrexic Cat).
          ● Fluid therapy to combat dehydration and electrolyte
            disturbances.
          ● Nutritional therapy is important to reduce the  Clinical signs
            hepatic workload and augment recovery.
                                                        Young cats (< 2 years old) and from a multicat envi-
            – Jejunostomy or gastrostomy tubes and feeding a
                                                        ronment are most susceptible.
               pureed commercial or esophagostomy tubes and
               feeding a commercial liquified diet are best tol-  Signs are referable to chronic inflammation of the kid-
               erated.                                  neys, liver, visceral lymph nodes, intestines, lungs, eyes
            – Feed a protein-modified diet as dictated by the  and brain.
               status of renal function and signs of hepatic
                                                        Chronic, progressive inappetance, weight loss, fever
               encephalopathy (rare).
                                                        and depression.
            – Control vomiting with famotidine (0.2 mg/kg
               SID PO) or metoclopramide (0.2–0.5 mg/kg q  Signs may be cyclical at first.
               8 h) or constant rate infusion at 1–2 mg/cat/24 h.
                                                        Jaundice and ascites may occur in cats with chronic
                                                        liver involvement.
          Prognosis                                     Dyspnea from pleural effusion occurs in about one in
                                                        five cats.
          Long-term follow-up on a large number of cats with
          cholangitis has not been performed.           CNS signs include seizures, personality changes, nys-
                                                        tagmus, head tremor and hyperesthesia.
          The prognosis with neutrophilic cholangitis is less
          favorable than for cats with lymphocytic cholangitis.  Vomiting may occur with granuloma formation in the
                                                        intestines, or inflammation in other organs such as the
          Cats with the neutrophilic form that survive the initial
                                                        liver.
          treatment period of several months have a reasonable
          chance for long-term survival.                Ocular signs include bilateral uveitis, perivascular exu-
                                                        dates, retinal hemorrhage or detachment.
          Cats with lymphocytic cholangitis may survive com-
          fortably for months to years with appropriate therapy.
                                                        Diagnosis
          Prevention                                    Diagnosis is based on history, clinical signs and char-
                                                        acteristic histologic lesions on tissue biopsy.
          Medical/surgical correction of biliary obstructive
                                                         ● Parenchymal lesions are characterized by multi-
          lesions when recognized.
                                                           focal hepatic necrosis with pyogranulomatous
          Treatment of inflammatory (lymphocytic-plasmacytic)  inflammation.
          lesions involving the intestinal mucosa (i.e., inflamma-  ● Pyogranulomas may be grossly evident on the cap-
          tory bowel disease).                             sule of the liver.
   433   434   435   436   437   438   439   440   441   442   443